These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

589 related items for PubMed ID: 16403441

  • 1. Targeted delivery of antibodies through the blood-brain barrier by MRI-guided focused ultrasound.
    Kinoshita M, McDannold N, Jolesz FA, Hynynen K.
    Biochem Biophys Res Commun; 2006 Feb 24; 340(4):1085-90. PubMed ID: 16403441
    [Abstract] [Full Text] [Related]

  • 2. Targeted drug delivery to the brain using focused ultrasound.
    Kinoshita M.
    Top Magn Reson Imaging; 2006 Jun 24; 17(3):209-15. PubMed ID: 17414078
    [Abstract] [Full Text] [Related]

  • 3. Ultrasound, microbubbles and the blood-brain barrier.
    Meairs S, Alonso A.
    Prog Biophys Mol Biol; 2007 Jun 24; 93(1-3):354-62. PubMed ID: 16959303
    [Abstract] [Full Text] [Related]

  • 4. Targeted gene delivery to the mouse brain by MRI-guided focused ultrasound-induced blood-brain barrier disruption.
    Huang Q, Deng J, Wang F, Chen S, Liu Y, Wang Z, Wang Z, Cheng Y.
    Exp Neurol; 2012 Jan 24; 233(1):350-6. PubMed ID: 22079586
    [Abstract] [Full Text] [Related]

  • 5. Effects of transcranial ultrasound and intravenous microbubbles on blood brain barrier permeability in a large animal model.
    Xie F, Boska MD, Lof J, Uberti MG, Tsutsui JM, Porter TR.
    Ultrasound Med Biol; 2008 Dec 24; 34(12):2028-34. PubMed ID: 18692294
    [Abstract] [Full Text] [Related]

  • 6. Macromolecular delivery across the blood-brain barrier.
    Hynynen K.
    Methods Mol Biol; 2009 Dec 24; 480():175-85. PubMed ID: 19085123
    [Abstract] [Full Text] [Related]

  • 7. Hemorrhage detection during focused-ultrasound induced blood-brain-barrier opening by using susceptibility-weighted magnetic resonance imaging.
    Liu HL, Wai YY, Chen WS, Chen JC, Hsu PH, Wu XY, Huang WC, Yen TC, Wang JJ.
    Ultrasound Med Biol; 2008 Apr 24; 34(4):598-606. PubMed ID: 18313204
    [Abstract] [Full Text] [Related]

  • 8. 2B-Trans technology: targeted drug delivery across the blood-brain barrier.
    Gaillard PJ, de Boer AG.
    Methods Mol Biol; 2008 Apr 24; 437():161-75. PubMed ID: 18369968
    [Abstract] [Full Text] [Related]

  • 9. Reengineering biopharmaceuticals for targeted delivery across the blood-brain barrier.
    Pardridge WM, Boado RJ.
    Methods Enzymol; 2012 Apr 24; 503():269-92. PubMed ID: 22230573
    [Abstract] [Full Text] [Related]

  • 10. Targeting rat anti-mouse transferrin receptor monoclonal antibodies through blood-brain barrier in mouse.
    Lee HJ, Engelhardt B, Lesley J, Bickel U, Pardridge WM.
    J Pharmacol Exp Ther; 2000 Mar 24; 292(3):1048-52. PubMed ID: 10688622
    [Abstract] [Full Text] [Related]

  • 11. Reversible blood-brain barrier disruption by repeated transcranial focused ultrasound allows enhanced extravasation.
    Yang FY, Lin YS, Kang KH, Chao TK.
    J Control Release; 2011 Feb 28; 150(1):111-6. PubMed ID: 21070825
    [Abstract] [Full Text] [Related]

  • 12. Delivery of peptides to the brain: emphasis on therapeutic development.
    Banks WA.
    Biopolymers; 2008 Feb 28; 90(5):589-94. PubMed ID: 18335425
    [Abstract] [Full Text] [Related]

  • 13. The targeted delivery of cancer drugs across the blood-brain barrier: chemical modifications of drugs or drug-nanoparticles?
    Juillerat-Jeanneret L.
    Drug Discov Today; 2008 Dec 28; 13(23-24):1099-106. PubMed ID: 18848640
    [Abstract] [Full Text] [Related]

  • 14. Delivery of therapeutic agents to the central nervous system: the problems and the possibilities.
    Begley DJ.
    Pharmacol Ther; 2004 Oct 28; 104(1):29-45. PubMed ID: 15500907
    [Abstract] [Full Text] [Related]

  • 15. Differential receptor-mediated drug targeting to the diseased brain.
    Rip J, Schenk GJ, de Boer AG.
    Expert Opin Drug Deliv; 2009 Mar 28; 6(3):227-37. PubMed ID: 19327042
    [Abstract] [Full Text] [Related]

  • 16. Biopharmaceutical drug targeting to the brain.
    Pardridge WM.
    J Drug Target; 2010 Apr 28; 18(3):157-67. PubMed ID: 20064077
    [Abstract] [Full Text] [Related]

  • 17. Targeted disruption of the blood-brain barrier with focused ultrasound: association with cavitation activity.
    McDannold N, Vykhodtseva N, Hynynen K.
    Phys Med Biol; 2006 Feb 21; 51(4):793-807. PubMed ID: 16467579
    [Abstract] [Full Text] [Related]

  • 18. Blood-brain barrier disruption in the treatment of brain tumors.
    Blanchette M, Fortin D.
    Methods Mol Biol; 2011 Feb 21; 686():447-63. PubMed ID: 21082387
    [Abstract] [Full Text] [Related]

  • 19. Humanization of anti-human insulin receptor antibody for drug targeting across the human blood-brain barrier.
    Boado RJ, Zhang Y, Zhang Y, Pardridge WM.
    Biotechnol Bioeng; 2007 Feb 01; 96(2):381-91. PubMed ID: 16937408
    [Abstract] [Full Text] [Related]

  • 20. Molecular Trojan horses for blood-brain barrier drug delivery.
    Pardridge WM.
    Discov Med; 2006 Aug 01; 6(34):139-43. PubMed ID: 17234133
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 30.